Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos

Journal of Steroid Biochemistry and Molecular Biology

Volumn 120, Issue 1, 2010, Pages 22-29

  Viswanath, Gunda ^a,b   Chatterjee, Shamba ^a   Dabral, Swati ^a,c   Nanguneri, Siddharth R ^a,d   Divya, Gunda ^a   Roy, Partha ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

^b UNIVERSITY OF UTAH   (United States)

^c International Max Planck Research School for Heart and Lung Research   (Germany)

^d MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

Author keywords

Androgen receptor; Anti androgenic; Endocrine disruptors; StAR; Steroidogenic enzymes

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN RECEPTOR; ANTIANDROGEN; CHLORPYRIFOS; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIC AMP; ENDOCRINE DISRUPTOR; ENDOSULFAN; LUCIFERASE; LUTEINIZING HORMONE RECEPTOR; PESTICIDE; PIPEROPHOS; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; ANDROGEN; AR PROTEIN, HUMAN; ORGANOPHOSPHORUS COMPOUND; PIPERIDINE DERIVATIVE;

ANDROGEN SYNTHESIS; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL VIABILITY; CHO CELL; CONTROLLED STUDY; DRUG POTENCY; ENZYME ACTIVITY; EVOKED RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEYDIG CELL; MALE; MALE GENITAL SYSTEM; NONHUMAN; PROTEIN EXPRESSION; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; STEROIDOGENESIS; TESTOSTERONE SYNTHESIS; ANIMAL; DOSE RESPONSE; GENETIC TRANSFECTION; IC 50; METABOLISM; MOUSE;

RATTUS;

ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; CHLORPYRIFOS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; GENES, REPORTER; HUMANS; INHIBITORY CONCENTRATION 50; LUCIFERASES; MALE; MICE; NIH 3T3 CELLS; ORGANOPHOSPHORUS COMPOUNDS; PIPERIDINES; RECEPTORS, ANDROGEN; TESTOSTERONE; TRANSFECTION;

EID: 77952300291     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.02.032     Document Type: Article

References (53)

1. Keller E.T., Ershler W.B., Chang C. The androgen receptor: a mediator of diverse responses. Front. Biosci. 1996, 1:59-71.
2. Roy P., Salminen H., Koskimies P., Simola J., Smeds A., Saukko P., Huhtaniemi I.T. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay. J. Steroid Biochem. Mol. Biol. 2004, 88:157-166.
3. Kelce W.R., Wilson E.M. Environmental anti-androgens: developmental effects, molecular mechanisms and clinical implications. J. Mol. Med. 2001, 75:198-207.
4. Blankvoort B.M.G., de Groene E.M., van Meeteren-Kreikamp A.P., Witkamp R.F., Rodenburg R.J.T., Aarts J.M.M.J.G. Development of an androgen reporter gene assay (AR-LUX) utilizing a human cell line with an endogenously regulated androgen receptor. Anal. Biochem. 2001, 298:93-102.
5. Chatterjee S., Majumder C.B., Roy P. Development of a yeast-based assay to determine the (anti)androgenic contaminants from pulp and paper mill effluents in India. Environ. Toxicol. Pharmacol. 2007, 24(2):114-121.
6. Schrader T.J., Cooke G.M. Examination of selected food additives and organochlorine food contaminants for androgenic activity in vitro. Toxicol. Sci. 2000, 53:278-288.
7. Wilson V.S., Bobseine K., Lambright C.R., Gray L.E. A novel cell line, MDA-kb2, that stably express an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol. Sci. 2002, 66:69-81.
8. Korner W., Vinggaard A.M., Terouanne B., Ma R., Wieloch C., Schlumpf M., Sultan C., Soto A.M. Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ. Health Perspect. 2004, 112(6):695-702.
9. Roy P., Franks S., Read M., Huhtaniemi I.T. Determination of androgen bioactivity in human serum samples using a recombinant cell based in vitro bioassay. J. Steroid Biochem. Mol. Biol. 2006, 101:68-77.
10. Chen J., Sowers M.R., Moran F.M., McConnell D.S., Gee N.A., Greendale G.A., Whitehead C., Kasim-Karakas S.E., Lasley B.L. Circulating bioactive androgens in midlife women. J. Clin. Endocrinol. Metab. 2006, 91(11):4387-4394.
11. Moore R.W., Jefcoate C.R., Peterson R.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol. Appl. Pharmacol. 1991, 109:85-97.
12. Ankley G.T., Jensen K.M., Durhan E.J., Makynen E.A., Butterworth B.C., Kahl M.D., Villeneuve D.L., Linnum A., Gray L.E., Cardon M., Wilson V.S. Effects of two fungicides with multiple modes of action on reproductive endocrine function in the fathead minnow (Pimephales promelas). Toxicol. Sci. 2005, 86(2):300-308.
13. Blystone C.R., Lambright C.S., Furr J., Wilson V.S., Gray L.E. Iprodione delays male rat pubertal development, reduces serum testosterone levels, and decreases ex vivo testicular testosterone production. Toxicol. Lett. 2007, 174:74-81.
14. Blystone C.R., Lambright C.S., Howdeshell K.L., Furr J., Sternberg R.M., Butterworth B.C., Durhan E.J., Makynen E.A., Ankley G.T., Wilson V.S. Sensitivity of fetal rat testicular steroidogenesis to maternal prochloraz exposure and the underlying mechanism of inhibition. Toxicol. Sci. 2007, 97(2):512-519.
15. Fowler P.A., Abramovich D.R., Haites N.E., Cash P., Groome N.P., Al-Qahtani A., Murray T.J., Lea R.G. Human fetal testis Leydig cell disruption by exposure to the pesticide dieldrin at low concentrations. Hum. Reprod. 2007, 22(11):2919-2927.
16. Howdeshell K.L., Wilson V.S. A mixture of five phthalate esters inhibits fetal testicular testosterone production in the Sprague Dawley rat in a cumulative, dose additive manner. Toxicol. Sci. 2008, 105(1):153-165.
17. Perkins E.J., Reyero N.G., Villeneuve D.L., Martinovic D., Brasfield S.M., Blake L.S., Brodin J.D., Denslow N.D., Ankley G.T. Perturbation of gene expression and steroidogenesis with in vitro exposure of fathead minnow ovaries to ketoconazole. Mar Environ Res. 2008, 66(1):113-115.
18. Chen J., Ahn K.C., Gee N.A., Ahmed M.I., Duleba A.J., Zhao L., Gee S.J., Hammock B.D., Lasley B.L. Triclocarban enhances testosterone action: a new type of endocrine disruptor?. Endocrinology 2008, 149(3):1173-1179.
19. Kumar V., Balomajumder C., Roy P. Disruption of LH-induced testosterone biosynthesis in testicular Leydig cells by triclosan: probable mechanism of action. Toxicology 2008, 250:124-131.
20. Jia X.C., Perlas E., Su J.G., Moran F., Lasley B.L., Ny T., Hsueh A.J. Luminescence luteinizing hormone/choriogonadotropin (LH/CG) bioassay: measurement of serum bioactive LH/CG during early pregnancy in human and macaque. Biol. Reprod. 1993, 49:1310-1316.
21. Viswanath G., Chatterjee S., Roy P. Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG). Mol. Cell. Endocrinol. 2007, 272:14-21.
22. Parthasarathy C., Balasubramanian K. Assessment of in vitro effects of metyrapone on Leydig cell steroidogenesis. Steroids 2008, 73(3):328-338.
23. Shiraishi K., Ascoli M. Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade. Endocrinology 2007, 148(7):3214-3225.
24. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2):55-63.
25. Kumar V., Chakraborty A., Viswanath G., Roy P. Androgenic endocrine disruptors in wastewater treatment plant effluents in India: their influence on reproductive processes and systemic toxicity in male rats. Toxicol. Appl. Pharmacol. 2008, 226:60-73.
26. Chatterjee S., Kumar V., Majumder C.B., Roy P. Screening of some anti-progestin endocrine disruptors using a recombinant yeast based in vitro bioassay. Toxicol. in Vitro 2008, 22:788-798.
27. Terouanne B., Tahiri B., Georget V., Belon C., Poujol N., Avances C., Orio F., Balaguer P., Sultan C. A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. Mol. Cell. Endocrinol. 2000, 160:39-49.
28. Xu L.C., Sun H., Chen J.F., Bian Q., Qian J., Song L., Wang X.R. Evaluation of androgen receptor transcriptional activities of bisphenol A, octylphenol and nonylphenol in vitro. Toxicology 2005, 216:196-203.
29. Sun H., Xu X.L., Xu L.C., Song L., Hong X., Chen J.F., Cui L.B., Wong X.R. Antiandrogenic activity of pyrethroid pesticides and their metabolite in reporter gene assay. Chemosphere 2007, 66:474-479.
30. Kemppainen J.A., Langley E., Wong C.I., Bobseine K., Kelce W.R., Wilson E.M. Distinguishing androgen receptor agonists and antagonists: direct mechanism of activation by medroxyprogesterone acetate and dihydrotestosterone. Mol. Endocrinol. 1999, 13:440-454.
31. Lee H.L., Lee Y.S., Kwon H.B., Lee K. Novel yeast bioassay system for detection of androgenic and antiandrogenic compounds. Toxicol. in Vitro 2003, 17(2):237-244.
32. S.H. Jeong, B.R. Kim, H.O. Ku, J.H. Choi, Studies on the assessment of endocrine disruption effects of animal feed additives and environmental contaminants in animal feeds, Annual Report on NVBQS 43-127.
33. Charles G.D., Kan H.L., Schisler M.R., Gollapudi B.B., Marty M.S. A comparison of in vitro and in vivo EDSTAC test battery results for detecting antiandrogenic activity. Toxicol. Appl. Pharmacol. 2005, 202:108-120.
34. Kojima H., Katsura E., Takeuchi S., Niiyama K., Kobayashi K. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ. Health Perspect. 2004, 112(5):524-531.
35. Yeh S., Chang H.C., Miyamoto H., Takatera H., Rahman M., Kang H.Y., Thin T.H., Lin H.K., Chang C. Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators. Keio J. Med. 1999, 48:87-92.
36. Murono E.P., Derk E.C., deLeon J.H. Biphasic effects of octylphenol on testosterone biosynthesis by cultured Leydig cells from neonatal rats. Reprod. Toxicol. 1999, 13:451-462.
37. Friedmann A.S. Atrazine inhibition of testosterone production in rat males following peripubertal exposure. Reprod. Toxicol. 2002, 16:275-279.
38. Murono E.P., Derk R.C. The effects of the reported active metabolite of methoxychlor, 2,2-bis(p-hydroxyphenyl)-1,1,1 trichloroethane, on testosterone formation by cultured Leydig cells from young adult rats. Reprod. Toxicol. 2004, 19(1):135-146.
39. Schurmeyer T., Nieschlag E. Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol. 1984, 105:275-280.
40. Kan P.B., Hirst M.A., Feldman D. Inhibition of steroidogenic cytochrome P-450 enzymes in rat testis by ketoconazole and related imidazole anti-fungal. J. Steroid Biochem. 1985, 23:1023-1029.
41. Kang H.G., Jeong S.H., Cho J.H., Kim D.G., Park J.M., Cho M.H. Chlorpyrifos-methyl shows anti-androgenic activity without estrogenic activity in rats. Toxicology 2004, 199:219-230.
42. Indarto D., Izawa M. Steroid hormones and endocrine disruptors: recent advances in receptor-mediated actions. Yonago Acta Med. 2001, 44:1-6.
43. Kang H.G., Jeong S.H., Cho J.H., Kim D.G., Park J.M., Cho M.H. Evaluation of estrogenic and androgenic activity of butylated hydroxyanisole in immature female and castrated rats. Toxicology 2005, 213:147-156.
44. Rice S., Mason H.D., Whitehead S.A. Phytoestrogens and their low dose combinations inhibit mRNA expression and activity of aromatase in human granulosa-luteal cells. J. Steroid Biochem. Mol. Biol. 2006, 101:216-225.
45. Chan M.Y., Huang H., Leung L.L. 2,3,7,8-Tetrachlorodibenzo-para-dioxin increases aromatase (CYP19) mRNA stability in MCF-7 cells. Mol. Cell. Endocrinol. 2010, 317(1-2):8-13.
46. Usmani K.A., Cho T.M., Rose R.L., Hodgson E. Inhibition of the human liver microsomal and human cytochrome P450 1°2 and 3°4 metabolism of estradiol by development-related and other chemicals. Drug Metab. Disposit. 2006, 34:1606-1614.
47. Usmani K.A., Rose R.L., Hodgson E. Inhibition and activation of the human liver microsomal and human cytochrome P450 3°4 metabolism of testosterone by development-related chemicals. Drug Metab. Disposit. 2003, 31:384-391.
48. Prins G.S. Endocrine disruptors and prostate cancer risk. Endocr.-Relat. Cancer 2008, 15:649-656.
49. Stocco D.M. The role of the StAR protein in steroidogenesis: challenges for the future. J. Endocrinol. 2000, 164(3):247-253.
50. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu. Rev. Physiol. 2001, 63:193-213.
51. Clark B.J., Soo S.C., Caron K.M., Ikeda Y., Parker K.L., Stocco D.M. Hormonal and developmental regulation of the steroidogenic acute regulatory (StAR) protein. Mol. Endocrinol. 1995, 9(10):1346-1355.
52. Sugawara T., Lin D., Halt J.A., Martin K.O., Javitt N.B., Miller W.L., Strauss J.F. Structure of the human steroidogenic acute regulatory protein (StAR) gene:StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 1995, 34:12506-12512.
53. Caron K.M., Ikeda Y., Soo S.C., Stocco D.M., Parker K.L., Clark B.J. Characterization of the promoter region of the mouse gene encoding the steroidogenic acute regulatory (StAR) protein. Mol. Endocrinol. 1997, 11:136-147.